← Search

The Review of Economics and Statistics Vol. 94 No. 4 2012

Investments in Pharmaceuticals Before and After TRIPS

Margaret Kyle1; Anita M. McGahan2,3

1 Toulouse School of Economics · 2 Harvard University · 3 University of Toronto

Abstract

The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the WTO, has increased levels of patent protection around the world. Using variation across countries in the timing of patent laws and the severity of disease, we test the hypothesis that increased patent protection results in greater drug development effort. We find that patent protection in wealthy countries is associated with increases in R&D effort. However, the introduction of patents in developing countries has not been followed by greater R&D investment in the diseases that are most prevalent there.

DOI
10.1162/rest_a_00214
Volume
94
Issue
4
Pages
1157-1172
Language
en
Sources
openalex crossref

Cite